CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

PearlMatrix® P-15 Peptide Enhanced Bone Graft Receives Medicare New Technology Add-on Payment (NTAP), Helping Hospitals Accelerate Lumbar Fusion

RegulatoryapprovedPearlMatrix P-15 Peptide Enhanced Bone GraftPositive
AI Analysis

Summary

Cerapedics' PearlMatrix P-15 Peptide Enhanced Bone Graft received Medicare New Technology Add-on Payment (NTAP), providing additional reimbursement to hospitals for lumbar fusion procedures. The product is positioned as the first and only bone growth accelerator demonstrating superior lumbar fusion speed.

Outcome Details

Medicare New Technology Add-on Payment (NTAP) received for PearlMatrix P-15

Importance:6/10
Sentiment:
0.80
MedicarereimbursementNTAPbone graftlumbar fusionregulatory approval
Related Companies

Read the original article

Published by PR Newswire Biotech on October 1, 2026 5:56 PM

Read Original